Search Within

Heather Jolie Landau

Formats
  1. Meeting Abstract (282)
  2. Journal Article (128)
  3. Research Letter (15)
  4. Book Section (5)
  5. Review (3)
  6. Correspondence (2)
  7. Conference Paper (1)
  8. Editorial (1)
  9. Guidelines (1)
Groups
  1. Bone Marrow Transplant (438)
  2. Center for Hematologic Malignancies (438)
  3. Department of Medicine (438)
  4. Hematologic Malignancies, Division of (438)
  5. Survivorship Research (438)
  6. Myeloma (249)

More Groups

People
  1. Sergio Giralt (263)
  2. Hani Hassoun (224)
  3. David Chung (207)
  4. Alexander Lesokhin (187)
  5. Gunjan Shah (164)
  6. Sham Mailankody (147)

More People

Years
  1. 2025 (16)
  2. 2024 (51)
  3. 2023 (48)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Blood (154)
  2. Clinical Lymphoma, Myeloma and Leukemia (53)
  3. Biology of Blood and Marrow Transplantation (48)
  4. Journal of Clinical Oncology (24)
  5. Bone Marrow Transplantation (12)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (166)
  2. Elsevier Inc. (111)
  3. Nature Publishing Group (30)
  4. American Society of Clinical Oncology (25)
  5. Taylor & Francis Group (21)
  6. Ferrata Storti Foundation (8)

More Publishers

Results (438)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosis
    Journal Article

    Jang, K. H.; Yu, A. F.; Landau, H.; Ma, X.; Cheng, R. K.; Mauer, M. S.; Lee Chuy, K.; Lenihan, D.; Yang, J. C.; Chen, C. L.; more...
    European Heart Journal Open (2025)

    Fulltext@MSK | Save
  • AST-KPCOP survey on clinical practice patterns in kidney transplants for plasma cell dyscrasia
    Meeting Abstract

    Boppana, S.; Blosser, C.; Webber, A.; Gupta, G.; Singh, N.; Master, S.; Parasuraman, R.; Campagnaro, E. L.; Java, A.; Sprangers, B.; more...
    American Journal of Transplantation (2025)

    Fulltext@MSK | Save
  • Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma
    Journal Article

    Adegbite, B.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience
    Journal Article

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
    Blood Neoplasia (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma
    Correspondence

    Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma
    Journal Article

    Sidana, S.; Ahmed, N.; Akhtar, O. S.; Brazauskas, R.; Oloyede, T.; Bye, M.; Hansen, D.; Ferreri, C.; Freeman, C. L.; Afrough, A.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
    Journal Article

    Einarsdottir, S.; Lobaugh, S.; Luan, D.; Gomez-Llobell, M.; Subramanian, P.; Devlin, S.; Chung, D.; Dahi, P. B.; Falchi, L.; Giralt, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
    Research Letter

    Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • The impact of melphalan conditioning and CD34(+) cell dose and schedule on post-transplant outcomes in AL amyloidosis
    Journal Article

    Muchtar, E.; Sanchorawala, V.; Hassan, H.; Hegenbart, U.; Schönland, S.; Lee, H. C.; Qazilbash, M.; Kin, A.; Zonder, J.; Jacob, E.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis
    Journal Article

    Muchtar, E.; Dispenzieri, A.; Sanchorawala, V.; Hassan, H.; Mwangi, R.; Maurer, M.; Buadi, F.; Lee, H. C.; Qazilbash, M.; Kin, A.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save